Mpox

UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East

Mpox Recent News

Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine
Tonix Pharmaceuticals and Bilthoven Biologicals have partnered to advance TNX-801, a promising mpox vaccine candidate based on horsepox. Backed by the world's largest vaccine manufacturer, the collaboration aims to enhance pandemic preparedness and develop a platform for other infectious diseases.
Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?
Applied DNA Sciences stock surges as it seeks approval to expand its mpox virus test to cover additional clades. The company awaits a decision from NYSDOH following its validation package submission, aiming to broaden its diagnostics services in New York and beyond.
Virax Biolabs Announces Stock Offering: What To Know
Virax Biolabs shares are trading lower Thursday after the company announced a $5 million registered direct offering of ordinary shares. Here's a look at what's going on:
Snowflake, GeoVax, Zoom, Target, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Wednesday, major U.S. indices were positive, with the Dow Jones Industrial Average rising 0.1% to 40,890.49.
GeoVax Labs Stock Surges Ahead Of The Close, Shares Remain Volatile: What's Happening?
GeoVax Labs shares popped ahead of the close on Wednesday and continue to bounce around in extended trading following a report suggesting Wayne County confirmed its first case of mpox since 2022.
GeoVax Stock Is Tumbling Tuesday: What's Going On?
GeoVax entered into a definitive securities purchase agreement with a certain institutional investor for the purchase and sale of 1.7 million shares of its common stock for $5 per share in a registered direct offering priced above-the-market under Nasdaq rules.
Virax Biolabs Shares Climb With Mpox Cases: What To Know
Virax Biolabs shares are racing higher Monday as shares of mpox-related stocks climb after the World Health Organization (WHO) declared the virus a global health emergency last week. Here's a look at what's going on:
Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study
Shares of SIGA Technologies (SIGA) had a 'bull trap' on Wednesday. There may be another one today. This can mean the stock is headed lower.
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
Bavarian Nordic submits data to European Medicines Agency seeking approval to extend Imvanex vaccine use to adolescents. New trials in younger children planned as global demand for smallpox and mpox vaccines rises.
Mpox Declared A Global Public Health Emergency By WHO Amid Rapid International Spread
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
A public health emergency for mpox in Africa saw vaccine stocks jump Wednesday. A look at the stocks and what's next for fighting the virus.
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
Shares of GeoVax Labs and SIGA Technologies are surging Wednesday amid Mpox Emergency Declaration. Here's what you need to know.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved